PASS-based prediction of metabolites detection in biological systems

References

• J. Kirchmair (ed.), Drug Metabolism Prediction, Wiley‐VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, 2014.
   Google Scholar
• B. Prasad, A. Garg, H. Takwani, and S. Singh, Metabolite identification by liquid chromatography-mass spectrometry, Trends Anal. Chem. 30 (2011), pp. 360–387. doi:10.1016/j.trac.2010.10.014.
   Web of Science ®Google Scholar
• M. Zhu, H. Zhang, and W.G. Humphreys, Drug metabolite profiling and identification by high-resolution mass spectrometry, J. Biol. Chem. 286 (2011), pp. 25419–25425. doi:10.1074/jbc.R110.200055.
   PubMed Web of Science ®Google Scholar
• P.P. Plehiers, G.B. Marin, C.V. Stevens, and K.M. Van Geem, Automated reaction database and reaction network analysis: Extraction of reaction templates using cheminformatics, J. Cheminform. 10 (2018), pp. 1–18. doi:10.1186/s13321-018-0269-8.
   PubMed Web of Science ®Google Scholar
• H. van de Waterbeemd, High-throughput and in silico techniques in drug metabolism and pharmacokinetics, Curr. Opin. Drug Discov. Devel. 5 (2002), pp. 33–43.
   PubMedGoogle Scholar
• N. Issa, H. Wathieu, A. Ojo, S. Byers, and S. Dakshanamurthy, Drug metabolism in preclinical drug development: A survey of the discovery process, toxicology, and computational tools, Curr. Drug Metab. 18 (2017), pp. 556–565. doi:10.2174/1389200218666170316093301.
   PubMed Web of Science ®Google Scholar
• R. Bugnon and A. Biosciences, The biochemistry of drug metabolism – An introduction: Part 1. Principles and overview, Chem. Biodivers. 3 (2006), pp. 1053–1101. doi:10.1002/cbdv.200690111.
   PubMed Web of Science ®Google Scholar
• L. Jia and X. Liu, The conduct of drug metabolism studies considered good practice (II): In vitro experiments, Curr. Drug Metab. 8 (2007), pp. 822–829. doi:10.2174/138920007782798207.
   PubMed Web of Science ®Google Scholar
• Safety Testing of Drug Metabolites Guidance for Industry Safety Testing of Drug Metabolites, Guidance for Industry, U.S. Department of Health and Human Services Food and Drug Administration CDER, 2016.
   Google Scholar
• T. Ddi, T. European, M. Agency, and E. Bioana, A tiered approach to address regulatory drug metabolite-related issues in drug development, Bioanalysis 6 (2014), pp. 587–590. doi:10.4155/bio.14.40.
   PubMed Web of Science ®Google Scholar
• J. Kirchmair, M.J. Williamson, J.D. Tyzack, L. Tan, P.J. Bond, A. Bender, and R.C. Glen, Computational prediction of metabolism: Sites, products, SAR, P450 enzyme dynamics, and mechanisms, J. Chem. Inf. Model. 52 (2012), pp. 617–648. doi:10.1021/ci200542m.
   PubMed Web of Science ®Google Scholar
• A.V. Rudik, V.M. Bezhentsev, A.V. Dmitriev, D.S. Druzhilovskiy, A.A. Lagunin, D.A. Filimonov, and V.V. Poroikov, MetaTox: Web application for predicting structure and toxicity of xenobiotics’ metabolites, J. Chem. Inf. Model. 57 (2017), pp. 638–642. doi:10.1142/S0219720019400018.
   PubMed Web of Science ®Google Scholar
• A.V. Rudik, A.V. Dmitriev, V.M. Bezhentsev, A.A. Lagunin, D.A. Filimonov, and V.V. Poroikov, Prediction of metabolites of epoxidation reaction in MetaTox, SAR QSAR Environ. Res 28 (2017), pp. 833–842. doi:10.1080/1062936X.2017.1399165.
   PubMed Web of Science ®Google Scholar
• D.A. Filimonov, D.S. Druzhilovskiy, A.A. Lagunin, T.A. Gloriozova, A.V. Rudik, A.V. Dmitriev, P.V. Pogodin, and V.V. Poroikov, Computer-aided prediction of biological activity spectra for chemical compounds: Opportunities and limitation, Biomed. Chem. Res. Meth. 1 (2018), pp. e00004. doi:10.18097/BMCRM00004.
   Google Scholar
• K.A. Murtazalieva, D.S. Druzhilovskiy, R.K. Goel, G.N. Sastry, and V.V. Poroikov, How good are publicly available web services that predict bioactivity profiles for drug repurposing? SAR QSAR Environ. Res 28 (2017), pp. 843–862. doi:10.1080/1062936X.2017.1399448.
   PubMed Web of Science ®Google Scholar
• V.V. Poroikov, D.A. Filimonov, Y.V. Borodina, A.A. Lagunin, and A. Kos, Robustness of biological activity spectra predicting by computer program pass for noncongeneric sets of chemical compounds, J. Chem. Inf. Comput. Sci. 40 (2000), pp. 1349–1355. doi:10.1021/ci000383k.
   PubMedGoogle Scholar
• A. Rudik, A. Dmitriev, A. Lagunin, D. Filimonov, and V. Poroikov, SOMP: Web server for in silico prediction of sites of metabolism for drug-like compounds, Bioinformatics 31 (2015), pp. 2046–2048. doi:10.1093/bioinformatics/btv087.
   PubMed Web of Science ®Google Scholar
• P.V. Pogodin, A.A. Lagunin, D.A. Filimonov, and V.V. Poroikov, PASS Targets: Ligand-based multi- target computational system based on a public data and naïve Bayes approach, SAR QSAR Environ. Res 26 (2015), pp. 783–793. doi:10.1080/1062936X.2015.1078407.
   PubMed Web of Science ®Google Scholar
• Biovia Metabolite database, BIOVIA, San Diego.
   Google Scholar
• P. Dorado, R. Berecz, and M.C. Caceres, Analysis of diclofenac and its metabolites by high-performance liquid chromatography : Relevance of CYP 2C9 genotypes in diclofenac urinary metabolic ratios, J Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789 (2003), pp. 437–442. doi:10.1016/S1570-0232(03)00137-5.
   PubMed Web of Science ®Google Scholar
• R. Bort, K. Mace, and A. Pfeifer, Hepatic metabolism of diclofenac : Role of human CYP in the minor oxidative pathways, Biochem. Pharmacol. 58 (1999), pp. 787–796. doi:10.1016/S0006-2952(99)00167-7.
   PubMed Web of Science ®Google Scholar
• D. Pontes, New metabolites of coumarin detected in human urine using ultra performance liquid, Molecules 22 (2017), pp. E2031. doi:10.3390/molecules22112031.
   PubMed Web of Science ®Google Scholar